Clinical Trial Update: BALANCE+ Vanguard Phase [NA]

View source ↗

Summary

The BALANCE+ Vanguard Phase study sponsored by Sunnybrook Health Sciences Centre has completed for Gram-negative bacteremia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gram-negative Bacteremia

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Gram-negative Bacteremia | NA | Status: COMPLETED